long-chain triglyceride

DRUG2 trials

Sponsors

Sino-Swed Pharmaceutical Corporation, Cerecin

Conditions

Alzheimer's DiseaseCarcinoma SurgeryParenteral NutritionPost-Operative Hospital Stay

Phase 2

AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

WithdrawnNCT01211782

CerecinAlzheimer's Disease

Updated: 2012-12-04

Phase 3

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

CompletedNCT00292279

Sino-Swed Pharmaceutical CorporationCarcinoma Surgery, Parenteral Nutrition, Post-Operative Hospital Stay

Start: 2002-06-30End: 2004-02-29Updated: 2008-05-14